These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26110827)

  • 1. ABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs.
    Nicoletti P; Bansal M; Lefebvre C; Guarnieri P; Shen Y; Pe'er I; Califano A; Floratos A
    PLoS One; 2015; 10(6):e0131038. PubMed ID: 26110827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine.
    Ciccacci C; Politi C; Mancinelli S; Ciccacci F; Lucaroni F; Novelli G; Marazzi MC; Palombi L; Borgiani P
    J Antimicrob Chemother; 2018 Aug; 73(8):2137-2140. PubMed ID: 29762688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
    Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
    Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Br J Ophthalmol; 2008 Jul; 92(7):989-91. PubMed ID: 18577653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.
    Ueta M; Sawai H; Sotozono C; Hitomi Y; Kaniwa N; Kim MK; Seo KY; Yoon KC; Joo CK; Kannabiran C; Wakamatsu TH; Sangwan V; Rathi V; Basu S; Ozeki T; Mushiroda T; Sugiyama E; Maekawa K; Nakamura R; Aihara M; Matsunaga K; Sekine A; Gomes JÁ; Hamuro J; Saito Y; Kubo M; Kinoshita S; Tokunaga K
    J Allergy Clin Immunol; 2015 Jun; 135(6):1538-45.e17. PubMed ID: 25672763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study of serious blistering skin rash caused by drugs.
    Shen Y; Nicoletti P; Floratos A; Pirmohamed M; Molokhia M; Geppetti P; Benemei S; Giomi B; Schena D; Vultaggio A; Stern R; Daly MJ; John S; Nelson MR; Pe'er I;
    Pharmacogenomics J; 2012 Apr; 12(2):96-104. PubMed ID: 21221126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.
    Génin E; Schumacher M; Roujeau JC; Naldi L; Liss Y; Kazma R; Sekula P; Hovnanian A; Mockenhaupt M
    Orphanet J Rare Dis; 2011 Jul; 6():52. PubMed ID: 21801394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L
    Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.
    Nakatani K; Ueta M; Khor SS; Hitomi Y; Okudaira Y; Masuya A; Wada Y; Sotozono C; Kinoshita S; Inoko H; Tokunaga K
    Sci Rep; 2019 Nov; 9(1):16240. PubMed ID: 31700100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
    Chung WH; Hung SI
    J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility.
    Ciccacci C; Latini A; Politi C; Mancinelli S; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1253-1259. PubMed ID: 28689274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
    Tohkin M; Kaniwa N; Saito Y; Sugiyama E; Kurose K; Nishikawa J; Hasegawa R; Aihara M; Matsunaga K; Abe M; Furuya H; Takahashi Y; Ikeda H; Muramatsu M; Ueta M; Sotozono C; Kinoshita S; Ikezawa Z;
    Pharmacogenomics J; 2013 Feb; 13(1):60-9. PubMed ID: 21912425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese.
    Maekawa K; Nishikawa J; Kaniwa N; Sugiyama E; Koizumi T; Kurose K; Tohkin M; Saito Y
    Drug Metab Pharmacokinet; 2012; 27(4):447-50. PubMed ID: 22277675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
    Borgiani P; Di Fusco D; Erba F; Marazzi MC; Mancinelli S; Novelli G; Palombi L; Ciccacci C
    Eur J Clin Pharmacol; 2014 Mar; 70(3):275-8. PubMed ID: 24322967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications.
    Ueta M
    Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI
    Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.